Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015694 |
---|---|
Receipt number | R000018240 |
Scientific Title | Safety and efficacy of haploidentical hematopoietic stem-cell transplantation followed by post-transplant high-dose cyclophosphamide (RIC) |
Date of disclosure of the study information | 2015/01/01 |
Last modified on | 2020/01/23 22:59:43 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/11/14 16:14:56 | ||
2 | Update | 2020/01/21 11:27:24 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Institute Organization Organization Organization Category of Funding Organization Organization1 Tel1 Email1 Organization Organization Address Address Tel |
|
3 | Update | 2020/01/21 11:31:53 | Number of participants that the trial has enrolled |
|
4 | Update | 2020/01/21 11:33:06 | Last follow-up date |
|
5 | Update | 2020/01/21 11:44:38 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
6 | Update | 2020/01/21 11:48:48 | Recruitment status Date of IRB |
|
7 | Update | 2020/01/21 22:56:04 | Key secondary outcomes Key secondary outcomes |
|
8 | Update | 2020/01/23 22:59:43 | Key exclusion criteria Key exclusion criteria |